IFF · International Flavors & Fragrances Inc
$84.18
+0.12 (+0.14%)
At close · Aug 14
Market Cap
$21.45B
Shares
255.15M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Rustom Jilla | CFO Nicolas Mirzayantz | $2,549,494 |
| Matthias Haeni | Former Divisional Chief Executive Officer, Taste Anne Chwat | $1,631,234 |
| Richard O’Leary | — | $1,602,359 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Divisional Chief | Executive Officer, Scent | $2,431,341 |
| Former CFO | — | $1,862,399 |
| Richard O’Leary | CFO Nicolas Mirzayantz | $1,862,399 |
| Matthias Haeni | Former Divisional Chief Executive Officer, Taste Anne Chwat | $1,742,273 |
| Former General | Counsel | $1,494,206 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Matthias Haeni | Former Divisional Chief Executive Officer, Taste Anne Chwat | $4,285,390 |
| Divisional Chief | Executive Officer, Scent | $2,088,528 |
| Richard O’Leary | CFO Nicolas Mirzayantz | $2,064,020 |
| Former CFO | — | $2,064,020 |
| Former General | Counsel | $1,762,347 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Matthias Haeni | Divisional Chief Executive Officer, Taste Anne Chwat | $3,156,660 |
| Divisional Chief | Executive Officer, Scent | $2,572,065 |
| Richard O’Leary | CFO Nicolas Mirzayantz | $1,895,797 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Richard Mulligan | independent director | Appointed | 2025-10-22 |
| Brett Icahn | director | Appointed | 2025-10-22 |
| Margarita Paláu-Hernández | director | Resigned | 2025-10-22 |
| Vincent Intrieri | director | Resigned | 2025-10-22 |
| Marc Birenkrant | Controller & Chief Accounting Officer | Appointed | 2025-08-07 |
| Paul Fribourg | board of directors | Appointed | 2025-07-30 |
| Jesus Mantas | board of directors | Appointed | 2025-07-30 |
| Virginia Drosos | director | Appointed | 2025-06-09 |
| Jennifer Johnson | Executive Vice President, General Counsel and Corporate Secretary | Resigned | 2025-03-13 |
| Leticia Goncalves Lourenço | President of the Company's Health & Biosciences division | Appointed | 2025-02-20 |
| Mehmood Khan | director | Appointed | 2024-12-19 |
| Cynthia Jamison | director | Appointed | 2024-12-19 |
| Vincent Intrieri | Icahn Designee director | Appointed | 2024-12-19 |
| Kevin O'Byrne | Chair of the Board | Appointed | 2024-12-19 |
| John Davidson | director | Retired | 2024-12-19 |
| Christina Gold | director | Retired | 2024-12-19 |
| Roger W. Ferguson, Jr. | Chair of the Board | Retired | 2024-12-19 |
| Glenn Richter | Executive Vice President, Chief Financial Officer | Retired | 2024-12-10 |
| Michael DeVeau | Executive Vice President, Chief Financial Officer | Appointed | 2024-12-10 |
| Margarita Paláu-Hernández | director | Appointed | 2024-05-30 |
| Glenn Richter | Chief Financial and Business Transformation Officer | Retired | 2024-05-06 |
| J. Erik Fyrwald | CEO | Appointed | 2024-01-11 |
| J. Erik Fyrwald | Director | Appointed | 2024-01-11 |
| Franklin K. Clyburn, Jr. | Director | Resigned | 2024-01-11 |
| Roger W. Ferguson, Jr. | Chair of the Board | Appointed | 2023-04-12 |
Key facts
CIK
51253
CUSIP
459506101
13F (30d)
586 filings
558 filers
Visit website
Investor relations